Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on August 12, 2026

Aug. 12, 2026

Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance

Indeterminate GlobeNewswire

Aug. 12, 2026

Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434

Indeterminate GlobeNewswire

Aug. 12, 2026

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process

Indeterminate GlobeNewswire

Aug. 12, 2026

Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis

Indeterminate GlobeNewswire

Aug. 12, 2026

TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

Kamada Announces Planned Transition of Chief Financial Officer

Indeterminate GlobeNewswire

Aug. 12, 2026

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer

Indeterminate GlobeNewswire

Aug. 12, 2026

Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

Indeterminate GlobeNewswire

Aug. 12, 2026

Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics

Indeterminate GlobeNewswire

Aug. 12, 2026

Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

Indeterminate GlobeNewswire

Aug. 12, 2026

Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones

Indeterminate GlobeNewswire

Aug. 12, 2026

Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study

Indeterminate GlobeNewswire

Aug. 12, 2026

Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases

Indeterminate GlobeNewswire

Aug. 12, 2026

Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement

Indeterminate GlobeNewswire

Aug. 12, 2026

ダーク・ホース・コンサルティング・グループが中国に進出、カン・リウをシニアディレクター兼中国事業責任者に任命

Indeterminate GlobeNewswire

Aug. 12, 2026

다크호스 컨설팅 그룹, 중국 시장 진출하며 강 리우 중국사업 총괄 수석이사 선임

Indeterminate GlobeNewswire